/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2016-09-22 17:06:502021-01-07 12:21:53Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2016-05-04 16:58:542021-01-07 12:21:59Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2015-08-29 16:56:582021-01-07 12:22:05Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2015-07-29 16:16:542021-01-07 12:22:10Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2014-11-26 16:24:562021-01-07 12:22:16Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphatase
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2014-02-24 16:45:172021-01-07 12:22:21Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential